Silk-fibroin tissue engineering technology platform
Business Model: Non-Profit
Revenue: $0
Employees: 11-50
Address:
City: Lomazzo
State: Lombardia
Zip:
Country: Italy
KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-human study on nerve repair that is ongoing at the University of Zurich, Switzerland
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2016 | Series A | 1 | $7.9M |
Principia SGR Principia SGR |
12/2015 | Convertible Note | $533.2k | 7/2015 | Grant | 1 | $78.9k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
11/2021 | Convertible Note | 1 | $3.4M |
Principia SGR Principia SGR |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|